Moderna Inc

NASDAQ:MRNA   3:59:59 PM EDT
147.66
+11.86 (+8.73%)
4:27:13 PM EDT: $147.29 -0.37 (-0.25%)
Products

Moderna Says Submitted Request To FDA For Amendment To EUA To Allow For Fourth Dose Of Covid-19 Vaccine

Published: 03/18/2022 01:51 GMT
Moderna Inc (MRNA) - Moderna Submits Amendment to the Emergency Use Authorization for an Additional Booster Dose of Its Covid-19 Vaccine in the U.S.submitted Request to the FDA for an Amendment to Eua to Allow for a Fourth Dose of Its Covid-19 Vaccine in Adults 18 Years of Age and Older.
Submission is Based in Part on Recently Published Data Generated in the United States and Israel Following the Emergence of Omicron.
Clinical Trials Are Ongoing for Moderna's Omicron-specific Booster and a Bivalent Omicron-specific Booster.
Submission is Based in Part on Recently Published Data Generated in United States and Israel Following Emergence of Omicron.
Moderna - Request to Include Adults Over 18 Years of Age Was Made to Provide Flexibility for (cdc) and Healthcare Providers.